CLINICAL TRIALS PROFILE FOR OTIPRIO
✉ Email this page to a colleague
All Clinical Trials for OTIPRIO
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02600559 ↗ | Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes | Completed | Otonomy, Inc. | Phase 3 | 2015-10-01 | This is an 8-week, multicenter, open-label study in which eligible subjects with a history of otitis media requiring TT placement will receive 6 mg OTO-201 to each ear. The study is designed to evaluate the safety and efficacy of OTO-201 in subjects undergoing TT placement with common concurrent surgeries and any middle ear effusion status. |
| NCT02719158 ↗ | Dose Ranging Study of OTO-201 in AOMT | Completed | Otonomy, Inc. | Phase 2 | 2016-02-01 | Dose Ranging Study of OTO-201 in AOMT |
| NCT02801370 ↗ | Phase 3 Study of OTO-201 in Acute Otitis Externa | Completed | Otonomy, Inc. | Phase 3 | 2016-06-01 | This is a prospective, randomized, double-blind, sham-controlled, multicenter, Phase 3 study in which eligible subjects with acute otitis externa (AOE) will be randomized to receive a single administration of either 12 mg OTO-201 or Sham-Control (empty syringe) to the external auditory canal of the affected ear(s). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OTIPRIO
Condition Name
Clinical Trial Locations for OTIPRIO
Trials by Country
Clinical Trial Progress for OTIPRIO
Clinical Trial Phase
Clinical Trial Sponsors for OTIPRIO
Sponsor Name
